Invention Grant
US08236824B2 N-(pyrazole-3-yl)-benzamide derivatives as glucokinase activators
有权
N-（吡唑-3-基） - 苯甲酰胺衍生物作为葡糖激酶活化剂
- Patent Title: N-(pyrazole-3-yl)-benzamide derivatives as glucokinase activators
- Patent Title (中): N-（吡唑-3-基） - 苯甲酰胺衍生物作为葡糖激酶活化剂
-
Application No.: US12682049Application Date: 2008-09-09
-
Publication No.: US08236824B2Publication Date: 2012-08-07
- Inventor: Lars Thore Burgdorf , Norbert Beier , Johannes Gleitz , Ulrich Emde , Christine Charon , Denis Carniato
- Applicant: Lars Thore Burgdorf , Norbert Beier , Johannes Gleitz , Ulrich Emde , Christine Charon , Denis Carniato
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent Gesellschaft mit Beschränkter Haftung
- Current Assignee: Merck Patent Gesellschaft mit Beschränkter Haftung
- Current Assignee Address: DE Darmstadt
- Agency: Millen, White, Zelano & Branigan, P.C.
- Priority: EP07019692 20071009
- International Application: PCT/EP2008/007365 WO 20080909
- International Announcement: WO2009/046802 WO 20090416
- Main IPC: A61K31/4439
- IPC: A61K31/4439 ; A61K31/415 ; C07D401/06 ; C07D231/40 ; A61P3/04 ; A61P13/12
Abstract:
Novel heterocyclic compounds of the formula I in which R1, R2, R3, R4, R5, R6, R7, Alk and D have the meanings indicated in claim 1, are activators of glucokinase and can be used for the prevention and/or treatment of Diabetes Typ 1 and 2, obesity, neuropathy and/or nephropathy.
Public/Granted literature
- US20100210690A1 N-(PYRAZOLE-3-YL)-BENZAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS Public/Granted day:2010-08-19
Information query
IPC分类:
